Lurie Autism Institute Honors Dr. Huda Zoghbi with Inaugural Nancy Lurie Marks Prize

In a momentous occasion for autism research, the Lurie Autism Institute has announced Dr. Huda Y. Zoghbi as the first recipient of its prestigious Nancy Lurie Marks Prize for Autism Research. This prize is awarded to individuals demonstrating transformative contributions to the understanding and treatment of autism. The Institute, a collaboration between Children's Hospital of Philadelphia and Penn Medicine, aims to advance field discoveries and improve the lives of those affected by autism.

Dr. Zoghbi’s impressive credentials include her roles as a Distinguished Service Professor at Baylor College of Medicine and Director of the Duncan Neurological Research Institute at Texas Children's Hospital. Her innovative work has redefined our insight into the genetic and molecular mechanisms behind neurological disorders, especially those related to autism. By integrating diverse fields like human genetics, animal models, and neuroscience, she has shed light on the intricate relationship between gene regulation and neurological function.

Frances E. Jensen, the chair of the prize committee and Professor of Neurology at the University of Pennsylvania, remarked on Dr. Zoghbi's extensive influence in the sphere of autism research. Jensen noted, "Dr. Zoghbi's history of remarkable work in understanding autism's complexities and her dedication to advancing this field made her the perfect choice for this prestigious honor."

A highlight of Dr. Zoghbi's career is her pivotal discovery of the link between mutations in the MECP2 gene and Rett syndrome, a neurodevelopmental disorder associated with autism. This breakthrough not only enhanced our understanding of Rett syndrome but also established foundational concepts guiding current autism research, such as the significance of gene mutations and their impacts on neural development.

Dr. Zoghbi expressed her gratitude upon receiving the award, stating, "I am incredibly honored to receive the inaugural Nancy Lurie Marks Prize for Autism Research. This recognition is not just for me but also for the patients and families who inspire our work daily, along with the remarkable trainees and collaborators who contribute to our understanding of genetic disruptions in autism.” She emphasized her hope that ongoing research would lead to improved insights and treatments that could transform the lives of individuals with autism and their families.

The award, accompanied by a $100,000 monetary prize, serves to honor the legacy of Nancy Lurie Marks, whose philanthropic efforts have significantly advanced autism research and the support of affected families. Dr. Zoghbi's work exemplifies the kind of revolutionary discoveries that the Lurie Autism Institute seeks to foster in its mission to promote scientific exploration in the field.

Dr. Zoghbi will receive her award in a formal ceremony at the 2026 Lurie Autism Institute Symposium, scheduled for May 7, 2026, in Philadelphia, where she will deliver an invited lecture on her groundbreaking findings.

The establishment of the Lurie Autism Institute was made possible through generous donations from the Lurie Family Foundation and the Nancy Lurie Marks Family Foundation, aiming to accelerate advancements in autism research and care since its launch in June 2025. Their commitment to deepening the understanding of autism and enhancing outcomes is at the core of the Institute's vision.

For further information, visit Lurie Autism Institute.

In celebrating such milestones, the collaborative efforts of institutions like the Lurie Autism Institute pave the way for future innovations in autism research, nurturing hope for families and individuals navigating the challenges of autism.